Safety and efficacy of combined ropivacaine and sufentanil compared with ropivacaine for cesarean sections: A systematic review and meta-analysis

Hammad A. Fadlalmola, Amal M. Elhusein, Muayad S. Albadrani, Huda K. Masada, Adel MA Abdalla, Mariam Y Elhussain, Ehab I. El-Amin, Fatma MA Azeem

Abstract

Cesarean sections are the most common operations in the United States and one of the most common worldwide. Using the lowest possible dose of anesthetic that provides painless delivery with the lowest adverse events is a major concern. We investigated the efficacy and safety of combined ropivacaine and sufentanil by pooling data from relevant studies. We searched PubMed, Web of sciences, Scopus, and Cochrane Library until the end of December 2021 and included all records with data about combined ropivacaine and sufentanil. We used Review Manager to pool data as a mean difference for continuous outcomes or risk ratio for dichotomous outcomes with a 95% confidence interval. Methodological quality was appraised using version one of the Cochrane risks of bias tool. Seven Randomized clinical trials with a total sample size of 730 women were included; the mean age of enrolled parturients ranged from 28 to 35 years. We found that combined sufentanil and ropivacaine were significantly associated with decreased risk of being aware and nervous during CS (presented by Sedation level 1) (RR: 0.05, 95%CI [0.01,0.33], P=0.002), decreased risk of shivering (RR=0.29, 95%CI [0.19,0.44], P<0.00001), nausea (RR=0.62, 95%CI [0.41, 0.92], P=0.02), and vomiting (RR=0.27, 95% CI [0.12, 0.61], P=0.002). However, combined sufentanil and ropivacaine slightly were associated with late-onset of sensory blockade (MD=0.41, 95%CI [0.13, 0.68], P=0.004) and less motor blockade of leg flexion at hip joint presented by Bromage Scale 0 (RR=7.15 95%CI [2.71, 18.86], P<0.0001). Combined ropivacaine and sufentanil were associated with a reduction in visceral pain and lower risks of hypotension, shivering, nausea, and vomiting, compared to isolated ropivacaine, with no difference regarding the incidence of bradycardia. Although Combined ropivacaine and sufentanil were associated with a higher risk of pruritus, the incidence of pruritus was reportedly proportionate with the used dose of sufentanil. However, combined ropivacaine and sufentanil may slightly delay the onset of the sensory blockade to pinprick at T10 with less motor blockade but with a smaller probability for women to be aware and nervous during CS. (Afr J Reprod Health 2023; 27 [1]: 95-106).

Full Text:

PDF

References

ACOG Practice Bulletin No. 205: Vaginal Birth After

Cesarean Delivery. Obstetrics and gynecology 133,

e110-e127 (2019).

https://doi.org:10.1097/aog.0000000000003078

Alahuhta S, Kangas-Saarela T, Hollmén AI and Edström HH.

Visceral pain during caesarean section under spinal

and epidural anaesthesia with bupivacaine. Acta

anaesthesiologica Scandinavica 1990; 34, 95-98.

https://doi.org:10.1111/j.1399-6576.1990.tb03050.x

Celleno D, Parpaglioni R, Frigo MG and Barbati G.

Intrathecal levobupivacaine and ropivacaine for

cesarean section. New perspectives. Minerva

anestesiologica 2005; 71, 521-525.

Khaw KS, Ngan Kee WD, Wong M, Ng F and Lee A. Spinal

ropivacaine for cesarean delivery: a comparison of

hyperbaric and plain solutions. Anesthesia and

analgesia 2002; 94, 680-685; table of contents.

https://doi.org:10.1097/00000539-200203000-00037

Whiteside JB, Burke D and Wildsmith JA. Comparison of

ropivacaine 0.5% (in glucose 5%) with bupivacaine

5% (in glucose 8%) for spinal anaesthesia for

elective surgery. British journal of anaesthesia 2003;

, 304-308. https://doi.org:10.1093/bja/aeg077

Milligan KR. Recent advances in local anaesthetics for spinal

anaesthesia. European journal of anaesthesiology

; 21, 837-847.

https://doi.org:10.1017/s0265021504000158

Dresner M. There is no place in modern obstetrics for racemic

bupivacaine. International journal of obstetric

anesthesia 2006; 15, 41-43.

https://doi.org:10.1016/j.ijoa.2005.06.007

Irestedt L, Emanuelsson BM, Ekblom A, Olofsson C and

Reventlid H. Ropivacaine 7.5 mg/ml for elective

caesarean section. A clinical and pharmacokinetic

comparison of 150 mg and 187.5 mg. Acta

anaesthesiologica Scandinavica 1997; 41, 1149-1156.

https://doi.org:10.1111/j.1399-6576.1997.tb04857.x

Morton CP, Bloomfield S, Magnusson A, Jozwiak H and

McClure JH. Ropivacaine 0.75% for extradural

anaesthesia in elective caesarean section: an open

clinical and pharmacokinetic study in mother and

neonate. British journal of anaesthesia 1997; 79, 3-8.

https://doi.org:10.1093/bja/79.1.3

Ateser RY and Kayacan N. Intrathecal ropivacaine in

cesarean delivery. Nigerian journal of clinical

practice 2017; 20, 1322-1327.

https://doi.org:10.4103/1119-3077.219520

Zhang X, Wang J, An X-H, Chao Y-C, Bian Y, Xu Z and

Xu T. Optimum dose of spinal ropivacaine with or

without single intravenous bolus of S-ketamine during

elective cesarean delivery: a randomized, doubleblind, sequential dose-finding study. BMC Pregnancy

and Childbirth 2021; 21, 746.

https://doi.org:10.1186/s12884-021-04229-y

Liu S, Chiu AA, Carpenter RL, Mulroy MF, Allen HW, Neal

JM and Pollock JE. Fentanyl prolongs lidocaine spinal

anesthesia without prolonging recovery. Anesthesia

and analgesia 1995; 80, 730-734.

https://doi.org:10.1097/00000539-199504000-00014

Tejwani GA, Rattan AK and McDonald JS. Role of spinal

opioid receptors in the antinociceptive interactions

between intrathecal morphine and bupivacaine.

Anesthesia and analgesia 1992; 74, 726-734.

https://doi.org:10.1213/00000539-199205000-00018

Akerman B, Arweström E and Post C. Local anesthetics

potentiate spinal morphine antinociception.

Anesthesia and analgesia 1988; 67, 943-948.

Choi DH, Ahn HJ and Kim MH. Bupivacaine-sparing effect

of fentanyl in spinal anesthesia for cesarean delivery.

Regional anesthesia and pain medicine 2000; 25, 240-

https://doi.org:10.1016/s1098-7339(00)90005-1

Vertommen JD, Van Aken H, Vandermeulen E, Vangerven

M, Devlieger H, Van Assche AF and Shnider SM.

Maternal and neonatal effects of adding epidural

sufentanil to 0.5% bupivacaine for cesarean delivery.

Journal of clinical anesthesia 1991; 3, 371-376.

https://doi.org:10.1016/0952-8180(91)90178-p

Bachmann-Mennenga B, Veit G, Biscoping J, Steinicke B

and Heesen M. Epidural ropivacaine 1% with and

without sufentanil addition for Caesarean section.

Acta anaesthesiologica Scandinavica 2005; 49, 525-

https://doi.org:10.1111/j.1399-

2004.00580.x

Chen X, Qian X, Fu F, Lu H and Bein B. Intrathecal

sufentanil decreases the median effective dose (ED50)

of intrathecal hyperbaric ropivacaine for caesarean

delivery. Acta anaesthesiologica Scandinavica 2010;

, 284-290. https://doi.org:10.1111/j.1399-

2009.02051.x

Parpaglioni R, Baldassini B, Barbati G and Celleno D.

Adding sufentanil to levobupivacaine or ropivacaine

intrathecal anaesthesia affects the minimum local

anaesthetic dose required. Acta anaesthesiologica

Scandinavica 2009; 53, 1214-1220.

https://doi.org:10.1111/j.1399-6576.2009.02033.x

Higgins JPT, TJ, Chandler J, Cumpston M, Li T, Page MJ,

Welch VA (editors). Cochrane Handbook for

Systematic Reviews of Interventions. 2nd Edition.

Chichester (UK): John Wiley & Sons, 2019.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann

TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA,

Brennan SE, Chou R, Glanville J, Grimshaw JM,

Hróbjartsson A, Lalu MM, Li T, Loder EW, MayoWilson E, McDonald S, McGuinness LA, Stewart LA,

Thomas J, Tricco AC, WelchVA, WhitingP and

Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. 372, n71

(2021). https://doi.org:10.1136/bmj.n71 %J BMJ

Boutron IPM, Higgins JPT, Altman DG, Lundh A and

Hróbjartsson A. Chapter 7: Considering bias and

conflicts of interest among the included studies. In:

Higgins JPT, Thomas J, Chandler J, Cumpston M, Li

T, Page MJ, Welch VA (editors). Cochrane Handbook

for Systematic Reviews of Interventions version 6.2

(updated February 2021). Cochrane, 2021. Available

from www.training.cochrane.org/handbook.

Bachmann-Mennenga B, Veit G, Steinicke B, Biscoping J

and Heesen M. Efficacy of sufentanil addition to

ropivacaine epidural anaesthesia for Caesarean

section. Acta anaesthesiologica Scandinavica 49,

-537 (2005).

Qian XW, Chen XZ and Li DB. Low-dose ropivacainesufentanil spinal anaesthesia for caesarean delivery: a

randomised trial. International journal of obstetric

anesthesia 2008; 17, 309-314.

https://doi.org:10.1016/j.ijoa.2008.01.018

Chen X.R, Gao T, Zhang Y and Peng MQ. Addition of lowdose sufentanil to ropivacaine for reducing shivering

and visceral traction pain during cesarean section. The

Journal of international medical research 49,

(2021).

https://doi.org:10.1177/03000605211017000

Miao F, Feng K, Feng X, Fan L, Lang Y, Duan Q, Hou R,

Jin D and Wang, T. The Analgesic Effect of Different

Concentrations of Epidural Ropivacaine Alone or

Combined With Sufentanil in Patients After Cesarean

Section. Frontiers in pharmacology 2021; 12,

https://doi.org:10.3389/fphar.2021.631897

Dahlgren G, Hultstrand C, Jakobsson J, Norman M, Eriksson

EW and Martin H. Intrathecal sufentanil, fentanyl, or

placebo added to bupivacaine for cesarean section.

Anesthesia and analgesia 1997; 85, 1288-1293.

https://doi.org:10.1097/00000539-199712000-00020

Kallio H, Snäll EV, Suvanto SJ, Tuomas CA, Iivonen MK,

Pokki JP and Rosenberg PH. Spinal hyperbaric

ropivacaine-fentanyl for day-surgery. Regional

anesthesia and pain medicine 2005; 30, 48-54.

https://doi.org:10.1016/j.rapm.2004.11.002

Fournier R, Weber A and Gamulin Z. Intrathecal sufentanil

is more potent than intravenous for postoperative

analgesia after total-hip replacement. Regional

anesthesia and pain medicine 2005; 30, 249-254.

https://doi.org:10.1016/j.rapm.2005.01.011

Crossley AW. Peri-operative shivering. Anaesthesia 1992;

, 193-195. https://doi.org:10.1111/j.1365-

1992.tb02114.x

Liu J, Wang Y and Ma, W. Shivering prevention and

treatment during cesarean delivery under neuraxial

anesthesia: a systematic review. Minerva

anestesiologica 2018; 84, 1393-1405.

https://doi.org:10.23736/s0375-9393.18.12478-3

Techanivate A, Rodanant O, Tachawattanawisal, W and

Somsiri T. Intrathecal fentanyl for prevention of

shivering in cesarean section. Journal of the Medical

Association of Thailand = Chotmaihet thangphaet

; 88, 1214-1221.

Xu GH, Gao M, Sheng, QY, Liu XS and Gu EW. Opioid

receptor A118G polymorphism does not affect the

consumption of sufentanil and ropivacaine by patient-controlled epidural analgesia after cesarean section.

Therapeutic drug monitoring 2015; 37, 53-57.

https://doi.org:10.1097/ftd.0000000000000112

Berti M, Danelli G, Antonino FA, Moizo E, Vinciguerra F

and Casati A. 0.2% ropivacaine with or without

sufentanil for patient-controlled epidural analgesia

after anterior cruciate ligament repair. Minerva

anestesiologica 2005; 71, 93-100.

Cai S, Zheng J, Meng Q, Chai J, Ma R, Wang Y, Zhang W

and Yang Z. Investigation of the Minimum Local

Analgesic Concentration of Epidural Sufentanil

Combined With Ropivacaine for Labor Analgesia.

Clinical therapeutics 2020; 42, 210-219.

https://doi.org:10.1016/j.clinthera.2019.10.011

Refbacks

  • There are currently no refbacks.